OMERS ADMINISTRATION Corp Raises Stake in GE HealthCare Technologies Inc. $GEHC

OMERS ADMINISTRATION Corp grew its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 53.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,832 shares of the company’s stock after purchasing an additional 7,922 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in GE HealthCare Technologies were worth $1,625,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Western Wealth Management LLC lifted its stake in shares of GE HealthCare Technologies by 2.4% during the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after buying an additional 125 shares in the last quarter. United Community Bank boosted its holdings in GE HealthCare Technologies by 10.2% in the 4th quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after buying an additional 130 shares during the period. Parkside Financial Bank & Trust increased its stake in GE HealthCare Technologies by 3.9% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,567 shares of the company’s stock worth $293,000 after buying an additional 134 shares in the last quarter. Quadrant Capital Group LLC increased its stake in GE HealthCare Technologies by 1.1% in the 4th quarter. Quadrant Capital Group LLC now owns 12,557 shares of the company’s stock worth $1,030,000 after buying an additional 140 shares in the last quarter. Finally, Mount Vernon Associates Inc. MD raised its holdings in GE HealthCare Technologies by 0.8% during the first quarter. Mount Vernon Associates Inc. MD now owns 18,165 shares of the company’s stock valued at $1,293,000 after acquiring an additional 144 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 12.2%

Shares of GEHC stock opened at $71.90 on Thursday. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The stock’s 50-day moving average price is $63.83 and its 200-day moving average price is $70.69. The stock has a market capitalization of $32.71 billion, a price-to-earnings ratio of 17.20, a price-to-earnings-growth ratio of 1.74 and a beta of 0.72.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.29 billion for the quarter, compared to the consensus estimate of $5.26 billion. During the same period in the previous year, the business earned $1.06 earnings per share. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is currently 3.35%.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, Director Rodney F. Hochman purchased 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares in the company, valued at $100,364.54. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Watkin Phoebe L. Yang acquired 1,000 shares of the stock in a transaction on Friday, May 8th. The shares were acquired at an average price of $63.01 per share, with a total value of $63,010.00. Following the transaction, the director directly owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders bought 15,928 shares of company stock valued at $1,005,761. 0.36% of the stock is owned by company insiders.

Key Stories Impacting GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GE HealthCare reported adjusted earnings of $1.13 per share, exceeding the $1.04 analyst consensus, while revenue reached approximately $5.29 billion versus expectations of $5.26 billion. Revenue rose about 5.8% year over year, helped by increased orders and healthy demand. GE HealthCare beats quarterly profit estimates on strong imaging demand, tariff refunds
• Positive Sentiment: Orders grew approximately 11% organically, book-to-bill reached a post-spin-off record near 1.15, and backlog climbed to a record $23.9 billion. The metrics provide stronger future revenue visibility and suggest hospitals are resuming capital investments in imaging and diagnostic infrastructure. GEHC Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Pharmaceutical Diagnostics delivered particularly strong growth, while imaging demand remained healthy. Management also said it is reviewing strategic alternatives for the underperforming Patient Care Solutions business, potentially allowing GE HealthCare to improve margins by restructuring or divesting the unit. GE HealthCare reports second quarter 2026 financial results
• Positive Sentiment: BTIG Research raised its GEHC price target from $75 to $79 and assigned a “Buy” rating, reinforcing the positive earnings reaction and suggesting additional upside based on the firm’s estimates. BTIG raises GE HealthCare price target
• Neutral Sentiment: Unusually high call-option activity showed traders purchasing roughly 8,956 contracts, about 45% above average. This reflects bullish speculative interest but does not directly change GE HealthCare’s fundamentals.
• Negative Sentiment: The earnings beat benefited from a tariff refund and a lower tax rate, which may not recur. Adjusted EBIT margins also contracted by roughly 40 basis points to about 14.2%, with Patient Care Solutions reporting a sharp organic revenue decline and negative EBIT.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Royal Bank Of Canada started coverage on GE HealthCare Technologies in a research note on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 price objective for the company. BTIG Research lifted their target price on GE HealthCare Technologies from $75.00 to $79.00 and gave the company a “buy” rating in a research note on Wednesday. JPMorgan Chase & Co. lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. Finally, Citigroup reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research report on Wednesday, July 8th. Ten investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average target price of $76.59.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.